The Diary of a CEOBenjamin Bikman: How insulin resistance silently grows fat
Bikman explains how eating carbohydrate often keeps insulin high: it tells fat cells to store, and the same loop quietly drives Alzheimer, PCOS, fatty liver.
CHAPTERS
- 0:00 – 2:14
Why insulin resistance is the hidden driver of modern disease (and why vaping may be worse)
Bikman frames insulin resistance as the common metabolic root behind many chronic diseases, from diabetes to infertility and Alzheimer’s. The conversation opens with a stark warning that vaping can worsen airway damage and insulin resistance, setting the urgency for the episode.
- •Vaping vs smoking: concerns about airway harm, inflammation, and insulin resistance
- •Insulin resistance presented as a core mechanism behind many chronic diseases
- •Insulin affects virtually every cell; resistance spreads dysfunction across organs
- •Tease of ‘fast vs slow’ insulin resistance and simple pillars to fix it
- 2:14 – 5:06
A mission to treat the ‘tree,’ not the ‘branches’ of chronic illness
Bikman explains his mission: chronic diseases are often treated as separate problems, but many share a single metabolic trunk. He argues lifestyle interventions can reduce risk across multiple major killers simultaneously, rather than ‘pruning’ symptoms with drugs alone.
- •Chronic diseases appear siloed but share a common origin
- •Medications often manage symptoms without addressing root cause
- •Lifestyle change as a multi-disease risk reducer
- •Insulin resistance introduced as the shared ‘metabolic core’
- 5:06 – 13:57
Insulin resistance explained simply: the ‘deaf cell’ + the ‘high insulin’ problem
Bikman breaks insulin resistance into two simultaneous realities: insulin doesn’t work as well in tissues, and insulin levels rise to compensate. He uses practical metaphors (taxis/bouncers) to show how glucose handling breaks down, then connects it to real outcomes like erectile dysfunction and PCOS.
- •Insulin’s role in lowering glucose and directing energy storage/use
- •Insulin resistance has two sides: impaired signaling + elevated insulin
- •Muscle as a major site of insulin-mediated glucose disposal
- •Vascular insulin resistance linked to erectile dysfunction; ovarian effects linked to PCOS
- 13:57 – 21:01
How insulin resistance develops: the ‘fast lane’ triggers (stress, inflammation, high insulin)
The discussion turns to causes, starting with rapid-onset insulin resistance. Bikman outlines three fast triggers—stress hormones, inflammation, and insulin itself—and emphasizes they can resolve quickly if the triggers are removed.
- •Stress hormones (cortisol/adrenaline) raise glucose and oppose insulin
- •Inflammation (infection/autoimmune flares) increases insulin resistance
- •High insulin can itself induce resistance (cells desensitize to constant stimulus)
- •Fast onset and fast reversal when triggers are removed
- 21:01 – 23:07
When it becomes chronic: constant eating, constant insulin, and the shift to ‘slow’ insulin resistance
Bikman explains how modern eating patterns keep insulin elevated all day, preventing metabolic recovery. This persistent insulin signaling sets up the slower, harder-to-reverse form of insulin resistance driven by changes inside fat tissue.
- •Frequent carb-heavy meals/snacks keep insulin elevated most waking hours
- •Insulin stays high longer than glucose after meals
- •Chronic hyperinsulinemia promotes fat-cell changes that worsen resistance
- •Transition to the ‘slow lane’ centered on fat tissue biology
- 23:07 – 25:51
Fat cells: why size matters more than total fat—and why insulin is a fat-storage signal
The episode dives into adipose biology: metabolic risk tracks more with fat-cell size than total fat mass. Bikman explains why women can carry more fat yet often remain more insulin sensitive, and why insulin is the critical signal that allows fat cells to grow.
- •Fat-cell size predicts inflammation and insulin resistance more than fat mass
- •Women tend to have more (but smaller) fat cells, offering metabolic protection
- •Most adults keep a fairly stable number of fat cells after puberty
- •Type 1 diabetes and lab experiments illustrate: without insulin, fat gain is impossible
- 25:51 – 40:43
Ethnicity, ‘personal fat threshold,’ and visceral vs subcutaneous fat risk
Bikman explains how ethnic differences in fat-cell number and fat distribution change metabolic risk at the same body weight. He introduces the ‘personal fat threshold’ and clarifies why visceral fat is more dangerous than subcutaneous fat.
- •East Asians often have fewer fat cells → earlier fat-cell enlargement and risk
- •Concept of personal fat threshold: capacity to store fat safely varies
- •Subcutaneous fat can expand via more/new fat cells; visceral fat grows by enlargement
- •Visceral fat is more metabolically harmful and space-limited around organs
- 40:43 – 46:00
Insulin resistance and women’s health: pregnancy, gestational diabetes, and long-term effects on the baby
The conversation distinguishes harmful insulin resistance from physiological insulin resistance during puberty and pregnancy. Bikman explains gestational diabetes as ‘type 2 diabetes of pregnancy’ and describes how maternal hyperglycemia/hyperinsulinemia can program the child’s future metabolic risk.
- •Physiological insulin resistance can be purposeful (puberty, pregnancy)
- •Pregnancy insulin resistance supports growth and glucose delivery to the fetus
- •Gestational diabetes: insulin resistance exceeds capacity to keep glucose normal
- •Offspring of gestational diabetes pregnancies have higher obesity and type 2 diabetes risk
- 46:00 – 51:33
Why some cancers (especially breast cancer) may track with insulin resistance
Steven raises a graph showing rising cancer incidence in younger women versus flatter trends in men. Bikman discusses detection effects, childbirth patterns, and a metabolic mechanism—tumors expressing more insulin receptors—linking hyperinsulinemia and growth signaling to cancer biology.
- •Possible artifact: increased screening and earlier detection in women
- •Breast cancer likely explains much of the female-driven rise
- •Tumors (e.g., breast) can have markedly more insulin receptors than nearby tissue
- •Insulin as a growth/fertilizer signal may accelerate tumor growth in insulin resistance
- 51:33 – 1:10:02
Alzheimer’s as ‘insulin resistance of the brain’: the energy-gap model and ketones as rescue fuel
Bikman argues Alzheimer’s research over-focused on plaques and missed metabolic dysfunction. He describes how brain insulin resistance limits glucose uptake, creating an energy gap that ketones can fill—linking similar hypometabolism patterns to depression, migraines, epilepsy, and Parkinson’s.
- •Critique of plaque-centric Alzheimer’s paradigm and research misdirection
- •Brain regions may require insulin to enable glucose entry; resistance blocks fuel
- •Brain glucose hypometabolism appears across multiple neurological disorders
- •Ketones can supply energy when glucose access is impaired
- 1:10:02 – 1:18:44
Longevity skepticism: correlational nutrition claims, autophagy, and insulin as the master lever
Asked about longevity gurus, Bikman contrasts weak evidence (surveys, correlations, animal extrapolation) with metabolic fundamentals. He centers longevity on insulin control, autophagy, and the balance between anabolic ‘build’ and catabolic ‘break’ processes.
- •Limits of correlational diet studies and unmeasured confounders (e.g., loneliness)
- •Autophagy framed as cellular ‘clean-up’ linked to longevity
- •Insulin strongly inhibits autophagy; lowering insulin may support longevity pathways
- •Ketogenic diets may promote autophagy even without calorie restriction (animal evidence)
- 1:18:44 – 1:22:15
Cholesterol and metabolic markers: ‘molecule of life’ vs modern marker obsession
Bikman challenges simplified ‘good vs bad’ cholesterol narratives and argues cholesterol is foundational to mitochondria and hormones. He criticizes healthcare incentives that prioritize markers with drug solutions (glucose/LDL) over potentially more informative ones (insulin/triglycerides).
- •Some longevity data associate good glucose control with higher cholesterol
- •Cholesterol’s roles: mitochondria function, hormone synthesis, immunity
- •LDL/HDL ‘good/bad’ framing seen as oversimplified
- •Critique: medicine measures what it can medicate (glucose/LDL) rather than insulin/triglycerides
- 1:22:15 – 1:31:04
Smoking, vaping, pollution, and plastics: non-food drivers of insulin resistance and fat gain
The episode returns to environmental and inhaled exposures as metabolic disruptors. Bikman cites evidence that smoking induces insulin resistance, vaping chemicals may be worse per exposure, and animal work links diesel particulates and microplastics/endocrine disruptors to fat-cell growth and inflammation.
- •Human evidence: smoking can induce insulin resistance quickly
- •Bikman’s research: vaping aerosols may be chemically harsher than cigarette smoke
- •Diesel exhaust particulates in animals increase fat-cell size and insulin resistance despite equal food intake
- •Microplastics and endocrine disruptors (e.g., BPA/DES-like compounds) may promote fat-cell growth
- 1:31:04 – 1:39:16
Ketosis 101: how ketones are made, why the brain loves them, and why fat loss accelerates
Bikman explains the biochemistry: insulin determines sugar-burning vs fat-burning, and prolonged low insulin drives the liver to produce ketones as a ‘release valve.’ He claims ketones improve brain function in impairment states and can raise fat-tissue metabolic rate, supporting faster fat loss.
- •Insulin as the switch controlling glucose vs fat oxidation
- •Ketones arise after sustained low insulin (fasting or keto) as liver over-burns fat
- •Case reports: ketosis improving functional tasks in early Alzheimer’s (clock drawing, shoelaces)
- •Research claim: ketosis increases belly-fat tissue metabolic rate and whole-body energy expenditure
- 1:39:16 – 1:55:26
Ketone supplements and Steven’s keto results: cognitive clarity, appetite control, and muscle concerns
They discuss ketone ‘shots’ (salts, esters, bioidentical BHB), what they might do acutely, and what evidence exists. Steven shares dramatic personal fat-loss and focus improvements on keto, then raises concerns about muscle loss—leading to guidance on hydration, salt, and adequate calories/fat.
- •Ketone products: salts vs esters vs bioidentical BHB; tradeoffs (minerals, cost, side effects)
- •Evidence strongest in animals for cognition; human performance effects discussed cautiously
- •Steven reports improved focus/energy stability, reduced hunger, and rapid belly-fat loss
- •Muscle preservation on keto: hydration/salt, resistance training, and sufficient calories/fat intake
- 1:55:26 – 2:19:23
Keto controversies: metabolic flexibility, the microbiome debate, sweeteners, salt, and the ‘4 pillars’ plan
Bikman addresses common objections: temporary reduced glucose tolerance when keto-adapted, and skepticism about microbiome alarmism. He then covers sweetener differences (insulin impact and blood-brain barrier concerns), reframes salt’s role in blood pressure/insulin resistance, and lays out four pillars: control carbs, prioritize protein, don’t fear fat, and fast appropriately.
- •Metabolic flexibility: keto-adapted bodies may clear a sudden carb load more slowly
- •Microbiome: evidence is noisy; ‘diversity = health’ is not proven, and clinical markers often improve on keto
- •Sweeteners: some are insulin-inert (aspartame, stevia, monk fruit, allulose); some sugar alcohols can cause GI issues; sucralose noted for blood-brain barrier concern
- •Salt: salt restriction can increase insulin resistance; hypertension framed as largely insulin-resistance driven
- •Four pillars: control carbs, prioritize protein, don’t fear fat, frequently fast (context-dependent)
- 2:19:23 – 2:39:25
Exercise, calorie restriction, Ozempic/GLP-1s, and why liposuction backfires metabolically
The final stretch focuses on practical interventions and pitfalls: resistance training for insulin sensitivity, skepticism of ‘eat less, move more’ as hunger-inducing, and a nuanced critique of GLP-1 drugs (lean mass loss, mood risks, best-use scenario). Bikman also explains why liposuction can worsen long-term metabolic health by reducing fat-cell capacity and shifting fat storage toward the abdomen.
- •Strength training is a powerful insulin-sensitizer; exercising muscle takes up glucose without insulin
- •Calorie restriction alone can backfire via hunger and metabolic adaptation (Biggest Loser example)
- •GLP-1 drugs: potential benefits for reducing cravings, but concerns about lean mass loss and mental health signals; advocate lowest effective dose + protein/fat + lifting
- •Liposuction removes fat cells rather than shrinking them, reducing storage capacity and promoting more harmful fat redistribution over time
- 2:39:25 – 2:43:50
Closing reflection: who believed in Bikman early on
In the closing tradition, Bikman answers a personal question about who believed in him when he doubted himself. He credits his wife’s trust and support during their early marriage as foundational to his career and family life.
- •Personal story: early fear about providing as a young newlywed
- •Wife’s belief and commitment enabled long-term stability
- •Balancing professional success with family presence
- •Episode wrap-up and thanks
